AnalysisNews

AVAH today

$11.50-$0.74 (-6.05%)close Nov 13, 2026

Trend

DailyUptrend (starting)

4 hourStrong Bearish

1 hourStrong Bearish

15 minLeaning Bullish

5 minStrong Bearish

Daily trend turns down below $8.76

Key levels

Resistance$12.53

Resistance$12.00

Support$11.32

Support$10.69

Latest news & SEC filings

EarningsAveanna Healthcare Hldgs holds Q3 2026 earnings call

EarningsAveanna Healthcare reports Q3 2026 results and revised guidance

GuidanceAveanna Healthcare lifts FY26 adjusted EBITDA guidance to above $374M from above $365M

All AVAH news →

About Aveanna Healthcare

Aveanna Healthcare delivers in-home care to patients with complex medical needs across the United States. Its operations cover private duty nursing and pediatric therapy, home health and hospice care for older adults, and a medical supplies business that provides enteral nutrition and respiratory equipment. Patients range from infants to seniors, and payments come from Medicare, Medicaid, and private insurance plans.

Based on the company's 10-K filed Mar 19, 2026.

Nasdaq · Healthcare

Aveanna Healthcare Holdings, Inc. (AVAH)

$11.50-0.74 (-6.05%)
WATCHLISTGrade: ARisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
12.0512.5913.1413.6811.50Oct 13Oct 21Oct 29Nov 6
High12.20
Low11.31
Open11.94
Volume3.96M
Avg Vol2.08M
VWAP11.51
30d High14.23
30d Low11.50
30d Chg-7.03%

What Is the Price Target for AVAH?

SEPT Low Target

$11.00

SEPT Mid Target

$15.00

SEPT High Target

$16.00

Analyst Consensus

$15.00

Current: $12.28Upside: +22.1%Confidence: 85%Method: Analyst Consensus

Is AVAH a Buy or Sell Right Now?

76
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Nov 12▲ UpEarnings5 articles
Aveanna Healthcare reported Q3 2026 results and held its quarterly earnings call, while also filing a Form 8-K on a major company event. The company raised its FY26 adjusted EBITDA guidance to above $374M from above $365M and projected FY2026 revenue above $2.695B, topping the $2.693B estimate. Despite these bullish revisions, AVAH shares fell 7.06% to close at $12.24, trading between a low of $12.15 and a high of $14.19 on volume of 4,628,990. The positive guidance signals an improved earnings outlook, though the sharp price decline suggests the market reacted negatively to other aspects of the report.

Thesis

  • •Revenue growing 20.2% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AVAH.

Start Free Trial →

Is AVAH Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/E Forward, P/B, PEG, Analyst Consensus

Fair Value

$12.71

54

Moat Score

NARROW

6/9

Piotroski Score

1.8

Altman Z-Score

What Is Smart Money Doing with AVAH?

Insider Signal

SELLING

0 buys / 19 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Stewart DeborahofficerBuy75,000-Oct 1, 2026
J.H. Whitney Equity Partners VII, LLC10% ownerSale2,250,000$25.9MAug 21, 2026
WILLIAMS ROBERT M JR10% ownerSale2,250,000$25.9MAug 21, 2026
VIGANO PAUL R10% ownerSale2,250,000$25.9MAug 21, 2026
Windley Rodney DdirectorSale180,000$2.1MAug 20, 2026
Shaner JeffofficerSale90,000$1.0MAug 20, 2026
J.H. Whitney Equity Partners VII, LLC10% ownerSale10,112,125$116.3MAug 20, 2026
J.H. Whitney Equity Partners VII, LLC10% ownerSale957,918$11.0MAug 20, 2026
J.H. Whitney Equity Partners VII, LLC10% ownerSale1,426,034$16.4MAug 20, 2026
WILLIAMS ROBERT M JR10% ownerSale10,112,125$116.3MAug 20, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

AVAH Growth Story

Revenue YoY

20.2%

3yr Revenue CAGR

10.8%

EPS Growth YoY

1850%

FCF Growth YoY

N/A%

Revenue Trend

ACCELERATING

Dark Pool Trades for AVAH

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for AVAH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:00:50$11.509,989$$115KSELL
21:00:25$11.503,057$$35KSELL
21:00:24$11.502,658$$31KSELL
21:00:24$11.5016,800$$193KSELL
21:00:24$11.502,084$$24KSELL

5 dark pool trades shown · $$398K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for AVAH

PREVIEW

SEPT Investing provides real-time options flow tracking for AVAH, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
CALL$12.5Jun 17216$$236511SWEEP
CALL$15Jun 17216$$151811SWEEP
CALL$15Jun 17216$$1251SWEEP
CALL$15Jun 17216$$1251SWEEP
CALL$15Jun 17216$$1261SWEEP

5 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

What Traders Are Saying About AVAH

1 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for AVAH. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

S
SEPT InvestingVERIFIED131d ago

SEPT Brain on $AVAH -- Bearish AVAH strong buying momentum at $8.66. Day range $8.40-$8.79. Last candle: strong bullish close (92% buying). Price in middle of zone $8.43-$8.79 — direction unclear, st...

286 views

Join 3,500+ traders discussing AVAH in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Aveanna Healthcare Holdings, Inc. (AVAH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

AVAH — frequently asked questions

What is AVAH stock price today?

Aveanna Healthcare Holdings, Inc. (AVAH) is at $11.50, down 6.05% (-$0.74) at the Nov 13, 2026 close.

Why is AVAH stock down today?

Nov 12, 2026: Aveanna Healthcare reported Q3 2026 results and held its quarterly earnings call, while also filing a Form 8-K on a major company event. The company raised its FY26 adjusted EBITDA guidance to above $374M from above $365M and projected FY2026 revenue above $2.695B, topping the $2.693B estimate.

What is the AVAH price target?

The average analyst price target for AVAH is $15.00, ranging from $11 to $16, based on 9 analysts. Latest: JP Morgan maintains on Sep 14, 2026.

What do analysts rate AVAH?

Analyst ratings for AVAH: 2 Buy, 14 Hold, 0 Sell — consensus Hold.

Did AVAH beat earnings?

AVAH last reported on Aug 13, 2026: EPS $0.18 vs $0.16 expected — a beat of 12.5%.

What is AVAH's P/E ratio?

AVAH trades at a P/E of 9.7 vs a Healthcare average of 17.4.

Does AVAH pay a dividend?

AVAH does not currently pay a dividend.

How much debt does AVAH have?

Aveanna Healthcare Holdings, Inc. reported $1.3B of debt and $97M of cash (Jul 4, 2026).

What are AVAH support and resistance levels?

Support: $11.32, $10.69, $10.00. Resistance: $12.00, $12.53, $13.53.

What are insiders doing with AVAH?

Insider activity: SELLING, 0 buys and 19 sells in the last 90 days.

What is the latest news on AVAH?

Nov 12, 2026: Aveanna Healthcare Hldgs holds Q3 2026 earnings call · Nov 12, 2026: Aveanna Healthcare reports Q3 2026 results and revised guidance · Nov 12, 2026: Aveanna Healthcare lifts FY26 adjusted EBITDA guidance to above $374M from above $365M